Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of faster-acting insulin aspart compared to NovoRapid® both in combination with insulin degludec in children and adolescents with type 1 diabetes.
Epistemonikos ID: 088014ab2ff54427d57a0cca88d315c97c81038a
First added on: May 12, 2024